YACOUB, MONA-RITA
 Distribuzione geografica
Continente #
NA - Nord America 3.579
EU - Europa 2.829
AS - Asia 2.459
SA - Sud America 387
Continente sconosciuto - Info sul continente non disponibili 228
AF - Africa 42
OC - Oceania 16
AN - Antartide 1
Totale 9.541
Nazione #
US - Stati Uniti d'America 3.374
RU - Federazione Russa 1.559
SG - Singapore 984
CN - Cina 790
IT - Italia 638
BR - Brasile 316
HK - Hong Kong 256
VN - Vietnam 193
DE - Germania 142
FR - Francia 129
CA - Canada 101
GB - Regno Unito 97
SE - Svezia 65
IN - India 61
NL - Olanda 56
BD - Bangladesh 40
FI - Finlandia 34
MX - Messico 30
TR - Turchia 23
AR - Argentina 22
PL - Polonia 21
AT - Austria 20
ES - Italia 19
JP - Giappone 17
IQ - Iraq 16
AU - Australia 15
ZA - Sudafrica 15
ID - Indonesia 12
CL - Cile 10
CO - Colombia 10
EC - Ecuador 10
GP - Guadalupe 10
SV - El Salvador 10
JM - Giamaica 8
TT - Trinidad e Tobago 8
CR - Costa Rica 7
HN - Honduras 7
JO - Giordania 7
SA - Arabia Saudita 7
CH - Svizzera 6
GT - Guatemala 6
LT - Lituania 6
MA - Marocco 6
MY - Malesia 6
PK - Pakistan 6
PY - Paraguay 6
DZ - Algeria 5
GR - Grecia 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
UA - Ucraina 5
VE - Venezuela 5
CW - ???statistics.table.value.countryCode.CW??? 4
KE - Kenya 4
NI - Nicaragua 4
PR - Porto Rico 4
PT - Portogallo 4
BE - Belgio 3
IE - Irlanda 3
IL - Israele 3
KR - Corea 3
NP - Nepal 3
PE - Perù 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BM - Bermuda 2
BO - Bolivia 2
BW - Botswana 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
PS - Palestinian Territory 2
SX - ???statistics.table.value.countryCode.SX??? 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
Totale 9.312
Città #
Singapore 554
Ashburn 440
San Jose 381
Moscow 347
Dallas 280
Hong Kong 252
Milan 183
Shanghai 152
New York 107
Council Bluffs 106
Hefei 102
Beijing 94
Lauterbourg 86
Los Angeles 86
Phoenix 73
Ho Chi Minh City 63
Rome 45
Atlanta 44
Boardman 44
Santa Clara 44
Hanoi 36
Munich 35
São Paulo 34
Guangzhou 30
Orem 29
Shenzhen 29
Nuremberg 28
Cesano Boscone 23
Chennai 23
Toronto 23
Chicago 22
Princeton 22
Brooklyn 21
Denver 21
Helsinki 21
Houston 21
London 20
Montreal 20
Naples 19
Amsterdam 18
Boston 17
Miano 17
Lawrence 16
Mexico City 16
San Francisco 16
Warsaw 15
Stockholm 14
Tokyo 14
Biên Hòa 13
Buffalo 13
Poplar 13
Rio de Janeiro 13
Jiaxing 12
Omaha 12
Bologna 11
Mumbai 11
Calgary 10
San Salvador 10
Washington 10
Brisbane 9
City of London 9
Falkenstein 9
Florence 9
Frankfurt am Main 9
Lappeenranta 9
Manchester 9
Seattle 9
Vienna 9
Wuxi 9
Ankara 8
Belo Horizonte 8
Buenos Aires 8
Cleveland 8
Haiphong 8
Johannesburg 8
Padova 8
St Petersburg 8
Amman 7
Contagem 7
Da Nang 7
Milwaukee 7
Ottawa 7
Brasília 6
Curitiba 6
Memphis 6
Pescara 6
Pittsburgh 6
Querétaro 6
San José 6
The Dalles 6
Turin 6
Wolfhagen 6
Athens 5
Changsha 5
Cologne 5
Dhaka 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Jakarta 5
Totale 4.520
Nome #
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 762
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 360
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 247
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media 173
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 169
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 166
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps 151
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 151
Severe asthma: One disease and multiple definitions 144
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 141
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 137
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 134
Evolving Clinical Manifestations and Symptom Clusters in Long-COVID Patients: a Comparative Analysis from April 2020 to Present 133
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results 133
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 126
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 125
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 124
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 122
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 120
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI ) 120
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 120
IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans 119
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study 117
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation 117
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 117
Assessment of impairment/disability due to occupational asthma through a multidimensional approach 116
Characteristics and treatment regimens across ERS SHARP severe asthma registries 115
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 114
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach 112
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey 109
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 103
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 97
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process 93
CLINICAL AND EPIDEMIOLOGICAL RELEVANCE OF ALLERGY IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN OBSERVATIONAL STUDY 93
Asthma caused by cyanoacrylate used in a leisure activity [2] 93
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis 92
Caring with compassion during COVID-19 92
Capitolo 80: Malattie allergiche 89
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study 89
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 88
Do environmental measures improve quality of life in mite-induced allergic rhinitis? 88
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 87
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 86
Occupational asthma and occupational rhinitis in hairdressers 84
Chronic rhinosinusitis with nasal polyps: a pilot study on immunologic dysregulation and the role of sensitisation to aeroallergens 84
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 83
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 83
EAACI position paper on occupational rhinitis 82
Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease 81
Drug induced exfoliative dermatitis: State of the art 77
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy 76
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 74
Eosinophils from Physiology to Disease: A Comprehensive Review 71
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 71
ITALIAN STUDY ON BUCKWHEAT ALLERGY: PREVALENCE AND CLINICAL FEATURES OF BUCKWHEAT-SENSITIZED PATIENTS IN ITALY 71
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 70
HYPERSENSITIVITY TO RITUXIMAB: A RAPID AND SIMPLIFIED DESENSITIZATION PROTOCOL FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND OTHER AUTOIMMUNE DISORDERS 69
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 69
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 68
Effects of sublingual immunotherapy on allergic inflammation: An update 67
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 67
Systemic allergic reactions induced by labile plant-food allergens: Seeking potential cofactors. A multicenter study 66
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 65
IgG4-related disease and allergen-specific immunotherapy 64
Optimal management of DRESS syndrome in course of infectious endocarditis. 64
Occupational rhinitis 62
World Trade Center disaster: Short- and medium-term health outcome 61
Resuscitation fluids 60
Unusual presentation of a serum sickness-like reaction due to sulfonamides 60
Is itIt's it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? The importance of desensitization procedures in the monoclonal antibodies era 59
Guidelines for the use and interpretation of diagnostic methods in adult food allergy 59
Occupational asthma due to bethabara wood dust 59
Occupational eosinophilic bronchitis 58
Pulmonary rehabilitation as evaluated by clinical trials: An overview 58
Omega-5 gliadin anaphylaxis: An integrated diagnostic approach 56
Immune mechanisms of allergen-specific immunotherapy 56
Effects of sublingual immunotherapy on allergic inflammation 56
Incidence and characteristics of hospital-acquired pneumonia in a pulmonary rehabilitation setting 55
Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: A case report 55
Usefulness of basophil activation test in gluten sensitivity 55
Erratum to "Guidelines for the use and interpretation of diagnostic methods in adult food allergy". [Clin Mol Allergy, 13, (2015), 27] DOI: 10.1186/s12948-015-0033-9 54
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 54
Histamine release test correlates with disease activity in chronic spontaneous urticaria 53
Usefulness of autologous serum and plasma skin tests in the diagnostic pathway of chronic idiopatic urticaria and/or autoimmune diseases and/or multiple drug allergy 53
Safety of sublingual immunotherapy started during the pollen season 53
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media. 53
Wheat gastrointestinal hypersensitivity: a case report 52
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 51
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium 50
Multiple drug hypersensivity: Insight into the underlying mechanism and correlation with autoimmune diseases 50
Is it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? 49
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor 49
Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order 48
Usefulness of skin testing in preventing hypersensitivity to iodinated contrast media 48
Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis 46
Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience 45
Evaluation of basophil activation test in suspected food hypersensitivity 43
Six-minute walk test cut-off value identifying COPD patients with physical disability: A pilot study 38
Beyond eosinophil depletion: Long-term clinical trajectory and durability of response to Benralizumab in patients with severe eosinophilic asthma and CRSwNP: an 18-month Real-World study (The BANDOR Study) 25
From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis 19
Totale 9.492
Categoria #
all - tutte 42.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 7 2 4 4 4 7 1 11 4
2022/2023116 35 24 9 0 2 15 7 8 3 3 4 6
2023/2024523 2 7 18 150 12 83 29 38 5 16 25 138
2024/20251.783 207 39 36 101 209 152 159 179 276 181 123 121
2025/20265.788 371 353 278 637 492 192 546 362 1.342 295 193 727
2026/20271.264 242 237 312 473 0 0 0 0 0 0 0 0
Totale 9.541